BioProcess International
 
 

Production


 

Considering Cell Culture Automation in Upstream Bioprocess Development

Tim Gryseels

BioProcess International, December 2008

 

With the increasing importance of biologics in today’s pharmaceutical market, throughput and efficiency are crucial in developing a production cell line. Cell culture automation can be a good solution for high-throughput and labor-intensive areas of a development process. Because of the cost of the investment, there are many factors to be considered before committing to a purchase.

 

In this paper, Tim Gryseels, a senior scientist at Pfizer, discusses the important steps in identifying and purchasing cell culture automation, and how the automation process can reduce costs and increase throughput, efficiency and consistency.

 

Download PDF

 
 

Targeted BPI Content
 

A Single-Use, Scalable Perfusion Bioreactor System
BioProcess International, June 2009
Learn more.

 

A Bioreactor System Based on a Novel Oxygen Transfer Method
BioProcess International, June 2008
Learn more.

 

Determining the Effect of Raw Materials on Manufacturing-Scale Cell-Culture Performance
An Application of Mechanistic Mathematical Models
BioProcess International, June 2008
Learn more.

A Review of Therapeutic Protein Expression By Mammalian Cells
BioProcess International, June 2008
Learn more.

Analytical Technology and PAT
BioProcess International, January 2007
Learn more.

 

Bioreactor Monitoring, Modeling, and Simulation
BioProcess International, January 2007
Learn more.

 

Whole-Genome Evolution Technology
Improving Protein and Antibody Yields in Scalable Mammalian-Cell-Based Manufacturing
BioProcess International, May 2006
Learn more.
 

Powered by Powered by PropelMG  
 
 
Visit BioProcess International Home